跳至主要内容
临床试验/JPRN-UMIN000012983
JPRN-UMIN000012983招募中未知

The maintenance therapy by Gemcitabine after the Gemcitabine(GEM)+Cisplatin (CDDP) combined therapy over a postoperative recurrence / advanced biliary tract cancer:a phase II, multicenter study - The maintenance therapy by Gemcitabine after the Gemcitabine(GEM)+Cisplatin (CDDP) combined therapy over a postoperative recurrence / advanced biliary tract cancer:a phase II, multicenter study

Kawasaki Medical School0 个研究点目标入组 25 人开始时间: 2014年1月28日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with an active concomitant malignancy 2) Patients with a previous history of a severe drug hypersensitivity 3) Patients with severe comobidities (pulmonary fibrosis or interstitial pneumonia, cardiovascular failure, renal failure, hepatic failure, hemorrhagic digestive ulcer, and gastrointestinal bleeding, intestinal tract paralysis, ileus, uncontrollable diabetes ). 4) Patients with an active concomitant infection 5) Pregnant, lactating female and patients of reproductive potential who did not use effective contraception 6) Patients with a severe mental disorder 7) Inappropriate patients for entry on this study in the judgement of the investigator

研究者

相似试验

The maintenance therapy by Gemcitabine after the... | 临床试验